Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs
Launched by PETER VILMANN MD, DSC, HC, FASGE · Dec 23, 2020
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients with a newly discovered SPL scheduled for EUS-guided tissue acquisition who can understand and provide a written consent.
- Exclusion Criteria:
- • Patients with uncorrected coagulopathies (INR \>1.5 or platelet count \<50,000) or patients treated with anticoagulants that cannot be discontinued.
- • Pregnant or lactating females.
- • Interposed, large vessels between the transducer and the target lesion.
About Peter Vilmann Md, Dsc, Hc, Fasge
Dr. Peter Vilmann, MD, DSC, HC, FASGE, is a distinguished clinical trial sponsor with extensive expertise in gastroenterology and advanced endoscopic techniques. With a robust academic background and numerous accolades, including Fellow of the American Society for Gastrointestinal Endoscopy, Dr. Vilmann is committed to advancing medical research and improving patient outcomes through innovative clinical trials. His leadership in the field is marked by a dedication to ethical standards and rigorous scientific methodologies, ensuring that each study contributes valuable insights to the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, Danmark, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials